Q2 2026 13F · SEC CIK 1532385
Genus Capital Management Inc.
Asset managerFiled 2026-07-29 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $1.0B
- Reported positions
- 204
- Top holdings a year, 3 yrs
- +36.9%
- Average holding period
- 1.5 yrs
Genus Capital Management Inc. is an asset manager that reported 204 positions worth $1.0B in its Q2 2026 13F, filed 2026-07-29. Its largest holdings were Nvidia Corporation (NVDA, 4.3%), Toronto Dominion Bk Ont (TD, 3.4%), Royal Bk Cda (RY, 3.2%). A portfolio copying its top holdings returned 36.9% a year over the last 3 years, against 24.2% for the S&P 500.
Genus Capital Management Inc. holdings largest 50 of 204 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
What Genus Capital Management Inc. bought and sold in Q2 2026, against Q1 2026.
New positions
Q1 2026's filing was too long to tell new positions apart.
Added to
- KLAC Kla Corp+660.9% shares
- MGA Magna Intl Inc+72.9% shares
- BIL Spdr Series Trust+67.2% shares
- USB US Bancorp+58.8% shares
- TXN Texas Instrs Inc+42.1% shares
- BMO Bank of Montreal+30.4% shares
- AAPL Apple Inc+20.6% shares
- GOVT Ishares Tr+16.6% shares
Reduced
- MRVL Marvell Technology Inc-49.2% shares
- GLW Corning Inc-49.0% shares
- NTR Nutrien Ltd-43.9% shares
- MU Micron Technology Inc-41.5% shares
- TGT Target Corp-30.5% shares
- GEV Ge Vernova Inc-24.9% shares
- AMD Advanced Micro Devices Inc-22.5% shares
- STX Seagate Technology Hldngs Pl-22.0% shares
Left the top 50
- GILD Gilead Sciences Incwas 1.9%
- IBM International Business Machswas 1.4%
- MRK Merck & Co Incwas 1.4%
- ULTA Ulta Beauty Incwas 1.0%
- HCA Hca Healthcare Incwas 1.0%
- HYG Ishares Trwas 0.9%
- TRV Travelers Companies Incwas 0.8%
- EMB Ishares Trwas 0.8%
Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.
How the holdings did against the S&P 500.
- 1 year
- +47.9% /yr
- S&P 500 +20.1%
- 3 years
- +36.9% /yr
- S&P 500 +24.2%
- 5 years
- —
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $1.0B | 204 |
| Q1 2026 | $872.6M | 189 |
| Q4 2025 | $858.5M | 195 |
| Q3 2025 | $861.8M | 201 |
| Q2 2025 | $778.7M | 182 |
| Q1 2025 | $689.6M | 182 |
| Q1 2024 | $770.1M | 197 |
| Q3 2023 | $635.4M | 179 |
| Q2 2023 | $679.2M | 193 |
Questions about Genus Capital Management Inc.'s portfolio
What stocks does Genus Capital Management Inc. own?
Genus Capital Management Inc.'s latest 13F, for Q2 2026 and filed Jul 29, 2026, lists 204 positions worth $1.0B. The largest are Nvidia Corporation (NVDA) at 4.3%, Toronto Dominion Bk Ont (TD) at 3.4%, Royal Bk Cda (RY) at 3.2%, Bank of Montreal (BMO) at 2.5% and Cisco Sys Inc (CSCO) at 2.5%.
What did Genus Capital Management Inc. buy last quarter?
In Q2 2026, Genus Capital Management Inc. added Kla Corp (KLAC) (+660.9% shares), Magna Intl Inc (MGA) (+72.9% shares) and Spdr Series Trust (BIL) (+67.2% shares), compared with its Q1 2026 filing.
What did Genus Capital Management Inc. sell last quarter?
In Q2 2026, Genus Capital Management Inc. cut from its top 50 Gilead Sciences Inc (GILD), cut from its top 50 International Business Machs (IBM), cut from its top 50 Merck & Co Inc (MRK), cut from its top 50 Ulta Beauty Inc (ULTA), cut from its top 50 Hca Healthcare Inc (HCA), Marvell Technology Inc (MRVL) (-49.2% shares), Corning Inc (GLW) (-49.0% shares) and Nutrien Ltd (NTR) (-43.9% shares), compared with its Q1 2026 filing.
How has Genus Capital Management Inc.'s portfolio performed?
A portfolio copying Genus Capital Management Inc.'s 20 largest 13F holdings each quarter, from the day each filing was public, returned +36.9% a year over the last 3 years, against +24.2% for the S&P 500. Over 1 year: +47.9% against +20.1%.
When is Genus Capital Management Inc.'s next 13F filing due?
13F filings are due 45 days after each quarter ends. Genus Capital Management Inc.'s filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.